Early into the COVID-19 pandemic, Dr. Marina Roytman, Liver Program Director, UCSF Fresno, began to notice a disturbing trend.
Patients were being admitted to Community Medical Centers hospitals with acute alcoholic hepatitis in increasing numbers. Alarmed, Dr. Roytman conducted a study to determine what was going on.
Dr. Roytman’s study monitored 300 patients for signs of acute alcoholic hepatitis then compared that data to the 2019 numbers. She found that after stay-at-home orders were put into place to slow the spread of COVID-19, the number of patients admitted for AH went up by 69%.
She adds, “And, in women, tragically, the admission rate went up by 125%.”